Table of Contents Table of Contents
Previous Page  140 / 1851 Next Page
Information
Show Menu
Previous Page 140 / 1851 Next Page
Page Background

Increase in pCR

Increase in pCR

Long CHT +

dual anti-HER2

therapy

Long CHT

+Trastuzumab

similar to short

CHT+dual anti-

HER2

Short CHT

+Trastuzumab

CHT alone

20%

48%

74%

38%

15%

25%

45%

65%